TECENTRIQ has helped people living with advanced urothelial carcinoma

In a clinical trial of TECENTRIQ with 119 patients with advanced urothelial carcinoma who could not receive cisplatin:

  • 23.5% of patients responded to treatment* 
  • More than 50% of patients who initially responded were still responding, with an average follow-up time of 14.4 months. When the data was collected, responses ranged from 3.7 to 16.6 months

In a clinical trial of TECENTRIQ with 310 patients with advanced urothelial carcinoma who were previously treated with chemotherapy that contained platinum:

  • 14.8% of patients responded to treatment* 
  • More than 50% of patients who initially responded were still responding, with an average follow-up time of 14.4 months. When the data was collected, responses ranged from 2.1 to 13.8 months

*In other words, the cancer was reduced or could no longer be detected on a scan.

Safety information you should be aware of

Possible serious side effects with TECENTRIQ include, but are not limited to, lung problems (pneumonitis), liver problems (hepatitis), intestinal problems (colitis), hormone gland problems (especially the thyroid, adrenal glands, pancreas, and pituitary), problems in other organs, severe infections and severe infusion reactions.

You can learn more about the signs and symptoms of these and other side effects in the TECENTRIQ Medication Guide.

Call or see your healthcare provider right away if you get any symptoms of these problems or these symptoms get worse.

The most common side effects of TECENTRIQ in people with urothelial carcinoma include:

  • feeling tired
  • decreased appetite
  • nausea
  • constipation
  • urinary tract infection
  • diarrhea
  • fever

Join TECENTRIQ On Your Side

Sign Up for TECENTRIQ® (atezolizumab) Support

Once you start TECENTRIQ, we can offer helpful information, tips, and resources.

Considering whether TECENTRIQ is right for you?

Tips to Talk to Your Doctor about TECENTRIQ® (atezolizumab)

Let us help you have an open discussion with your doctor about your care and treatment for advanced bladder cancer.